TITULO

Normal view MARC view ISBD view

Reduction of pharmaceutical expenditure by a drug appropriateness intervention in polymedicated elderly subjects in Catalonia (Spain) / Lluís Campins [i 5 més]

By: Campins, Lluís [autor].
Material type: materialTypeLabelArticleContent type: text Media type: informàtic Carrier type: recurs en líniaSubject(s): Receptes mèdiques | Despesa farmacèutica | Estudis de casos i controlOnline resources: Accés lliure
Contents:
Mateu Serra-Prat, Elisabet Palomera, Ignasi Bolibar, Miquel Àngel Martínez, Pedro Gallo
In: GACETA SANITARIA 2019 MAR-ABR; 33(2):106-111Summary: RESUM: Objective To assess the monetary savings resulting from a pharmacist intervention on the appropriateness of prescribed drugs in community-dwelling polymedicated (≥8 drugs) elderly people (≥70 years). Method An evaluation of pharmaceutical expenditure reduction was performed within a randomised, multicentre clinical trial. The study intervention consisted of a pharmacist evaluation of all drugs prescribed to each patient using the “Good Palliative-Geriatric Practice” algorithm and the “Screening Tool of Older Persons Prescriptions/Screening Tool to Alert doctors to Right Treatment” criteria (STOPP/START). The control group followed the routine standard of care. A time horizon of one year was considered and cost elements included human resources and drug expenditure. Results 490 patients (245 in each group) were analysed. Both groups experienced a decrease in drug expenditure 12 months after the study started, but this decrease was significantly higher in the intervention group than in the control group (−14.3% vs.−7.7%; p=0.041). Total annual drug expenditure decreased 233.75 €/patient (95% confidence interval [95%CI]: 169.83-297.67) in the intervention group and 169.40 €/patient (95%CI: 103.37-235.43) in the control group over a one-year period, indicating that 64.30 € would be the drug expenditure savings per patient a year attributable to the study intervention. The estimated return per Euro invested in the programme would be 2.38 € per patient a year on average. Conclusions The study intervention is a cost-effective alternative to standard care that could generate a positive return of investment.
List(s) this item appears in: Novetats bibliogràfiques. Articles. Març 2019
Tags from this library: No tags from this library for this title. Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Collection Call number Status Notes Date due Barcode
Journal article Journal article Escola Universitària d'Infermeria i Teràpia Ocupacional de Terrassa
Biblioteca
Paper Capses ordenades alfabèticament (Browse shelf) Exclòs de préstec Consulta a sala 0001017285930
Journal Journal Escola Universitària d'Infermeria i Teràpia Ocupacional de Terrassa
Biblioteca
Paper Capses ordenades alfabéticament (Browse shelf) Exclòs de préstec (Accés restringit) Consulta en Sala 28541

Mateu Serra-Prat, Elisabet Palomera, Ignasi Bolibar, Miquel Àngel Martínez, Pedro Gallo

RESUM: Objective
To assess the monetary savings resulting from a pharmacist intervention on the appropriateness of prescribed drugs in community-dwelling polymedicated (≥8 drugs) elderly people (≥70 years).

Method
An evaluation of pharmaceutical expenditure reduction was performed within a randomised, multicentre clinical trial. The study intervention consisted of a pharmacist evaluation of all drugs prescribed to each patient using the “Good Palliative-Geriatric Practice” algorithm and the “Screening Tool of Older Persons Prescriptions/Screening Tool to Alert doctors to Right Treatment” criteria (STOPP/START). The control group followed the routine standard of care. A time horizon of one year was considered and cost elements included human resources and drug expenditure.

Results
490 patients (245 in each group) were analysed. Both groups experienced a decrease in drug expenditure 12 months after the study started, but this decrease was significantly higher in the intervention group than in the control group (−14.3% vs.−7.7%; p=0.041). Total annual drug expenditure decreased 233.75 €/patient (95% confidence interval [95%CI]: 169.83-297.67) in the intervention group and 169.40 €/patient (95%CI: 103.37-235.43) in the control group over a one-year period, indicating that 64.30 € would be the drug expenditure savings per patient a year attributable to the study intervention. The estimated return per Euro invested in the programme would be 2.38 € per patient a year on average.

Conclusions
The study intervention is a cost-effective alternative to standard care that could generate a positive return of investment.

There are no comments for this item.

Log in to your account to post a comment.


   Recursos d´informació - Recursos de información - Information resources

Moodle
  • Bases de dades 

BVS 
ENFISPO   
 
  •  Bases de dades d'evidències

  • Cercadors acadèmics

 
  • Plataformes editorials

 
  • Portals temàtics

 
  •  Repositoris digitals

R
  • Revistes

 
  • Xarxes socials especialitzades en l'àmbit acadèmic

 
  • Més recursos 

Powered by Koha